FDA recalls 11,460 chlorthalidone tablets for failing dissolution tests

By United One News · AI-generated summary of 1 outlets' reporting

Published 28 Sept 2026, 19:56 UTC

AI-generated summary of the coverage listed below:

• The FDA issued a Class II recall of 11,460 bottles of chlorthalidone tablets made by Inventia Healthcare Limited after they failed dissolution specifications.
• The recall covers all affected products sold across the United States.

Covered by 1 outlet across the spectrum: 0% left, 0% center, 100% right.

How each side framed it

FDA Chlorthalidone Dissolution Testing Recall: Blood Pressure Medication Recalled Across US Under FDA’s Class II Risk Level, Fails ‘Dissolution Standards’

Timeline

First reported by Sunday Guardian on 28 Sept 2026, 19:56 UTC; 1 article from 1 outlets so far.

Who is covering this story

• Right-leaning (1): Sunday Guardian

Sources

• FDA Chlorthalidone Dissolution Testing Recall: Blood Pressure Medication Recalled Across US Under FDA’s Class II Risk Level, Fails ‘Dissolution Standards’ — Sunday Guardian (right-leaning) · 28 Sept 2026, 19:56 UTC

What an outlet bias classification means